Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Healthpoint Biotherapeutics Officially Takes Smith & Nephew Name - Medical Product Outsourcing
Columns

Healthpoint Biotherapeutics Officially Takes Smith & Nephew Name

Healthpoint Biotherapeutics Officially Takes Smith & Nephew Name

December last year, British orthopedic device company Smith & Nephew acquired Fort Worth, Texas-based Healthpoint Biotherapeutics, a wound care company, in a $782 million cash deal. A year later, Healthpoint is now making the transition to the Smith & Nephew name, taking on the parent company’s identity for future business. Healthpoint now will be known as Smith & Nephew Biotherapeutics.

At the time of the acquisition, Smith & Nephew officials said they would integrate Healthpoint into its wound management division gradually, so as not to disrupt business. “Assuming the Smith & Nephew name reflects the evolution of our organization as a biotherapeutic leader now operating within a multinational organization,” said Rob Bancroft, president of Smith & Nephew Biotherapeutics. “As well as continuing to market our existing products such as Santyl, we will retain our focus on the development and commercialization of novel, cost-effective biopharmaceuticals for dermal repair and regeneration.”

Smith & Nephew Biotherapeutics’ research and development strategy is centered around therapeutic enzymes, biologics and next-generation cell- and cell-matrix based therapies for the prevention and treatment of acute, chronic and burn-related wounds.

According to the company, bioactives are a rapidly growing area of wound care. Greater understanding of wound biology is driving the development of new biopharmaceuticals designed to stimulate the body’s own regenerative processes.

Smith & Nephew officials said the company intended to build upon Healthpoint’s strong presence in the United States. As stated last year, the business will continue to be headquartered in Fort Worth.

Add us as a preferred source on Google

Get the latest Medical Product Outsourcing news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters